Sibiriquinone B exhibits significant antimicrobial activity, particularly against Gram-positive bacteria, making it a candidate for development in antibacterial therapies. It has also shown cytotoxic effects on certain cancer cell lines, suggesting potential use in oncology for targeting tumor cells. Additionally, its role as a redox-active quinone allows it to participate in electron transfer processes, which may be harnessed in biochemical assays or biosensor technologies. Research is ongoing to explore its anti-inflammatory properties and possible applications in treating oxidative stress-related diseases.